Open AccessP32 Abatacept demonstrates consistent safety and sustained improvements in efficacy through 5 years of treatment in biologic-naïve patients with RA
Author(s) -
Gregory Macaraeg,
J.M. Kremer,
A. S. Russell,
P Emery,
Carlos AbudMendoza,
Jacek Szechiñski,
Jan C. Becker,
Guoyu Wu,
René Westhovens
Publication year - 2009
Publication title -
indian journal of rheumatology/indian journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 11
eISSN - 0973-3701
pISSN - 0973-3698
DOI - 10.1016/s0973-3698(09)60050-9
Subject(s) - medicine , abatacept , oncology , intensive care medicine , rituximab , lymphoma